The Johns Hopkins Richard W. TeLinde Gynecologic Pathology Research Program continues the tradition of its namesake by advancing science in studying gynecological diseases, and train scientists and physicians as the future leaders in the fields.  Dr. Richard W. TeLinde, the founding Chair of the Hopkins Department of Gynecology, was an accomplished physician, visionary researcher, and a dedicated educator. With his generosity, this inter-departmental Program was established in 1988 and is currently directed by Ie-Ming Shih, MD, PhD, who is the TeLinde Distinguished Professor and continues his legacy and fulfills his visions in gynecologic pathology research. The program primarily supports the Gynecologic Pathology Laboratory within the Department of Gynecology and Obstetrics. The program also supports and collaborates with investigators in the Department of Pathology and the Johns Hopkins Gynecologic Tumor bank.  Research activities of the Program faculty are reflected by reporting new discovery in gynecologic pathology and receiving several program grant awards from NIH Cervical Cancer SPORE, DoD Ovarian Cancer Consortium and NIH/NCI UO1 Early Detection Network in addition to individual research awards. Dr. Shih subscribes the vision from Alfred Knudsen, one of the pioneers in cancer genetics- caring for “ideas per square foot” more than “dollars per square foot".

TeLinde Professor and Program Director

Ie-Ming Shih, MD, PhD. Richard W. TeLinde Distinguished Professor and Director of the Johns Hopkins TeLinde Research Program, Department of Gynecology and Obstetrics; Co-director of the Breast and Ovarian Cancer Program, Sidney Kimmel Comprehensive Cancer Center;  Molecular genetics of ovarian and uterine cancer, Experimental therapeutics, Precursor lesions of ovarian and uterine cancer

Program Faculty

Stephanie Gaillard, MD, PhD. Assistant Professor of Gynecology and Obstetrics and Oncology; gynecologic cancer clinical trial, translational ovarian and endometrial cancer research


Kimberly Levinson, MD, PhD Assistant Professor of Gynecology and Obstetrics;  Gynecologic oncology, early detection of ovarian and cervical cancer early detection

TC Wu, MD, PhD. Professor of Pathology and Director of Gynecologic Pathology Division, Department of Pathology; HPV immunology, HPV therapeutic vaccine


Russel Vang, MD. Professor of Pathology, Director of Clniical Operation, Division of Gynecologic Pathology; Diagnostic gynecologic pathology; serous borderline tumor


Bridgett Ronnett, MD. Professor of Pathology; Diagnostic gynecologic pathology, molecular diagnosis of molar pregnancy, pathology of mucinous ovarian neoplasm, clinicopathological characterization of gynecologic neoplasms


Tian-Li Wang, PhD. Professor of Pathology; Cancer genomics, tumor modeling and chemo-prevention, molecular detection of uterine and ovarian cancer, Notch signaling in ovarian cancer, next-generation tumor banking, chromatin remodeling and DNA damage in ovarian cancer


Richard Roden, PhD. Professor of Pathology; HPV virology, HPV preventive vaccine; ovarian cancer pathogenesis, proteosome inhibitor, experimental therapeutics


Chien-Fu Hung, PhD. Associate Professor of Pathology; Ovarian cancer immunotherapy, cancer immunology, mouse tumor modeling for experimental therapy